Issue Information

Issue Information
Publié: (2025)

Issue Information
Publié: (2025)

Lower CD8+ T‐cell senescence partially mediates the neuroprotection of higher aerobic fitness
par: Bernadette A. Fausto, et autres
Publié: (2026)

Alzheimer's disease drug development pipeline: 2026
par: Jeffrey L. Cummings, et autres
Publié: (2026)

Infusion‐related reactions in donanemab‐treated participants with early symptomatic Alzheimer's disease
par: Paul Ardayfio, et autres
Publié: (2026)

Blood DNA methylation signature of cognitive reserve moderates the association between CSF tau pathology and memory in prodromal Alzheimer's disease
par: David Lukacsovich, et autres
Publié: (2026)

APOE ‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study
par: Mai Othman, et autres
Publié: (2026)

The words community dwelling, Spanish‐preferring Mexican/Mexican American adults use to talk about Alzheimer's disease and genetic testing: Implications for education and outreach
par: Jamie C. Fong, et autres
Publié: (2026)

A sex‐specific “hormone–bone–brain” axis in Alzheimer's disease: Integrating Global Burden of Disease data and Mendelian randomization analysis to reveal the causal role of osteocalcin
par: Zhiyang Zheng, et autres
Publié: (2026)

Biomarkers in Alzheimer's disease clinical trials: 2025
par: Amanda M. Leisgang Osse, et autres
Publié: (2026)

Association of Excessive Daytime Sleepiness With Long‐Term Incident Dementia: The Role of β‐Amyloid and White Matter Injury
par: Xiaowen Zhou, et autres
Publié: (2026)

Locus coeruleus alterations in dementia with Lewy bodies: A systematic review
par: Anaëlle Bain, et autres
Publié: (2026)

Brain networks modulating the relationship between white matter volume and cognition
par: Osamu Katayama, et autres
Publié: (2026)

Blood biomarkers for Alzheimer's disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitation
par: Maansi Barnwal, et autres
Publié: (2026)

From companionship to science: the importance of dogs in advancing translational research on Alzheimer's disease – a scoping review
par: Heloísa Máximo Ribeiro, et autres
Publié: (2026)

Weight loss and metabolic improvements dominate the microbiome response in the MIND diet intervention: a randomized controlled trial
par: Robin M. Voigt, et autres
Publié: (2026)

The momentum for dementia research in Brazil
par: Mychael V. Lourenco
Publié: (2026)

Functional connectome metrics reveal distinct prognostic subtypes in two Phase 3 gantenerumab trials
par: Susanna Gobbi, et autres
Publié: (2026)

Cognitive training, alone and combined with acetylcholinesterase inhibitors, in neurocognitive disorders: long‐term efficacy and the role of cognitive reserve on 30 months of intervention
par: Adele Ravelli, et autres
Publié: (2026)

Effects of care partner type on outcomes from a multicomponent behavioral intervention for mild cognitive impairment
par: Zhigang Xie, et autres
Publié: (2026)

Decentralizing dementia research to the US–Mexico border: the Rio Grande Valley AD‐RCMAR as a model for translational equity
par: Gladys E. Maestre, et autres
Publié: (2026)

Association between plasma p‐tau181 levels and the evolution of cognitive and physical performance in a cohort of cognitively impaired older adults with frailty criteria: Longitudinal data from the CogFrail study
par: Davide Angioni, et autres
Publié: (2026)

Pathway‐based polygenic risk of Alzheimer's disease highlights immune genes in cognitive decline
par: Emilija Romic, et autres
Publié: (2026)

Effects of multidomain intervention on cognitive function in older adults with cognitive impairment: A multicenter, four‐arm, cluster randomized trial
par: Zhaoxue Yin, et autres
Publié: (2026)

Impact of cognitive training on claims‐based diagnosed dementia over 20 years: evidence from the ACTIVE study
par: Norma B. Coe, et autres
Publié: (2026)

Mapping brain change longitudinally: physical activity intervention reshapes structural alterations and functional connectivity in Alzheimer's disease
par: Ravi Dadsena, et autres
Publié: (2026)

The I‐Learn Cognition and Behavior program for non‐pharmacological treatment of agitation in nursing home residents with neurocognitive disorders: A cluster randomized trial
par: Céline Lourdel, et autres
Publié: (2026)

Alzheimer's disease Stage 1 and 2: Biology, diagnostics, and treatment
par: Suzanne E. Schindler, et autres
Publié: (2026)

Differential relationships between cardiorespiratory fitness and cortical thickness across the adult lifespan: A generalized additive model approach
par: Jillian H. Graham, et autres
Publié: (2026)

Vascular cognitive impairment and dementia drug‐development pipeline 2025
par: Ying Xu, et autres
Publié: (2026)

Amyloid: An evolutionarily conserved protein to fight infection or a toxic protein that causes Alzheimer's disease?
par: Jahnavi Shriram, et autres
Publié: (2026)

EXPRESSION OF CONCERN: Focused Transcranial Ultrasound for Treatment of Neurodegenerative Dementia
Publié: (2026)

Acute anti‐Aβ antibody exposure induces microglial changes and significantly alters chemokine signaling
par: Kate E. Foley, et autres
Publié: (2026)

Study of the utility and impact of a plasma p‐tau181 Alzheimer's biomarker (SUITABLE)
par: Kyra O'Brien, et autres
Publié: (2026)

Real‐world relationship between blood biomarker‐based PhenoAge, metformin, and Alzheimer's disease
par: Yi Shi, et autres
Publié: (2026)

Sex differences in blood pressure hemodynamics and white matter hyperintensity volume across racial ethnic groups—HABS‐HD
par: Cellas A. Hayes, et autres
Publié: (2026)